APPLE ROBERT F (President & CEO) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2022ACC: 0001016169-22-000012
DirectorOfficer· President & CEO
Since Aug 2018
+42.61K
Net shares
Net buyer
$125.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
76.89K acquired · 34.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+76.89K
Price / share
—
Trade value
—
% of position
3.2%
2/16/2022
2.40M→2.47M
Common Stock
Direct
Shares
−34.28K
Price / share
$3.66
Trade value
$125.47K
% of position
1.4%
2/16/2022
2.47M→2.44M
Total
Net shares
+42.61K
Net value
-$125.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/16/2022 | A · Award | +76.89K | — | — | 3.2% | 2.40M | 2.47M |
| Common Stock Direct | 2/16/2022 | F · Tax Withholding | −34.28K | $3.66 | $125.47K | 1.4% | 2.47M | 2.44M |
| Total | +42.61K | -$125.47K | ||||||
Derivative Transactions0
No derivative transactions reported